Abstract
Cord blood (CB) as a new source of grafting material has evoked great expectations. Because it is derived from the fetus, it contains immature cells with unusual properties: they possess higher proliferation capacity for regenerating the hematopoietic system after ablative treatment than does grafting material gained from adults, and they retain differentiation capacities for some non-hematopoietic tissues as well. The main application today is straightforward use as sibling or unrelated allograft during myoablative treatment of malignant disease. Important indications are also given in children with inherited blood cell diseases, hemoglobinopathies, immune deficiencies and other genetic diseases such as osteopetrosis and storage diseases; beside this, new perspectives for tissue replacement in the case of organ damage in adults open up, and both applications foster a family-centered strategy for CB storage.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Douay, McNiece (2000) Contributions at the international conference on haematopoietic stem cell biology and transplantation, Paris, 25–29 March 2000
Gluckman E, Broxmeyer HE, Auerbach AD et al (1989) Hematopoietic reconstitution in a patient with Fanconi’s anemia by means of umbilical-cord blood from an HLA-identical sibling. N Engl J Med 321: 1174–1178
Gluckman E, Rocha V, Boyer-Chammard A et al (1997) Outcome of cord-blood transplantation from related and unrelated donors. N Engl J Med 337(6): 373–381
Gluckman E, Rocha V, Chastang CL (1999) Umbilical cord blood hematopoietic stem cell transplantation. Eurocord-Cord Blood Transplant Group. Cancer Treat Res 101: 79–96
Hénon Ph, Sovalat H, Becker M, Arkam Y, Ojeda-Oribe M, Raidot JP, Husseini F, Wunder E, Bouderont D, Audhuy B (1998) Primordial role of CD34+38-cells in early and late trilineage haemopoietic engraftment after autologous blood cell transplantation. Br J Haematol 103: 568–581
Kögler G, Somville T, Gobel U, Hackenberg P, Knipper A, Fischer J, Adams O, Krempe C, McKenzi C, Ruttgers H, Meier W, Bellmann O, Streng H, Ring A, Rosseck U, Rocha V, Wernet P (1999) Haematopoietic transplant potential of unrelated and related cord blood: the first six years of the Eurocord/Netcord Bank Germany. Klin Padiatr 211(4): 224–232
Kurtzberg J, Laughlin M, Graham ML et al (1996) Placental blood as a source of hematopoietic stem cells for transplantation into unrelated recipients. N Engl J Med 335: 157–166
Lampeter EF, Egger D (2000) Storage of cord blood for related or unrelated use. In: Schultze W (ed) High-dose therapy and transplantation of hematopoietic cells. Blackwell Wissenschafts-Verlag, Berlin
Leung W, Ramirez M, Civin CI (1999) Quantity and quality of engrafting cells in cord blood and autologous mobilized peripheral blood. Biol Blood Marrow Transplant 5(2): 69–76
Mayani H, Landsdorp PM (1998) Biology of human umbilical cord blood-derived hematopoietic stem/progenitor cells. Stem Cells 16: 153–165
Nieda M, Nicol A, Denning-Kendall P et al (1997) Endothelial cell precursors are normal components of human umbilical cord blood. Br J Haematol 98: 775–777
Piacibello W, Sanavio F, Garetto L et al (1997) Extensive amplification and self renewal of human primitive hematopoietic stem cells from cord blood. Blood 89(8): 2644–2653
Rawlings DJ, Quan SG, Kato RM et al (1995) Long-term culture system for selective growth of human B-cell progenitors. Proc Natl Acad Sci USA 92: 1570–1574
Rubinstein P, Carrier C, Scaradavou A et al (1998) Outcomes among 562 recipients of placental-blood transplants from unrelated donors. N Engl J Med 339(22): 1565–1567
To LB (1994) Establishment of a clinical threshold cell dose: correlation between CFU-GM and duration of aplasia. In: Wunder E, Sovalat H, Henon PR, Serke S (eds) Hematopoietic stem cells. Mulhouse Manual Alpha Med Press, Dayton OH
Vaziri H, Dragowska W, Allsopp RC, Thomas TE, Harley CB, Lansdorp PM (1994) Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci USA 91: 9857–9860
Wagner JE, Rosenthal J, Sweetman R et al (1996) Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease. Blood 795-802
Wang JCY, Doedens M, Dick JE (1997) Primitive human hematopoietic cells are enriched in cord blood compared with adult bone marrow or mobilized peripheral blood as measured by the quantitative in vivo SCID-repopulating cell assay. Blood 89: 3919–3924
Editor information
Rights and permissions
Copyright information
© 2001 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Wunder, E. (2001). Chances and Limits of Cord Blood Transplantation. In: Holzgreve, W., Lessl, M. (eds) Stem Cells from Cord Blood, in Utero Stem Cell Development and Transplantation-Inclusive Gene Therapy. Ernst Schering Research Foundation Workshop, vol 33. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-04469-8_5
Download citation
DOI: https://doi.org/10.1007/978-3-662-04469-8_5
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-04471-1
Online ISBN: 978-3-662-04469-8
eBook Packages: Springer Book Archive